Viewing Study NCT06859333


Ignite Creation Date: 2025-12-25 @ 2:59 AM
Ignite Modification Date: 2026-02-01 @ 3:36 PM
Study NCT ID: NCT06859333
Status: RECRUITING
Last Update Posted: 2025-07-08
First Post: 2025-02-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of the Safety, Tolerability, and Pharmacokinetic Profile of Ascending Doses of Ingavirin Forte, Capsules, Folliwing Single and Subsequent Multiple Oral Administration in Healthy Volunteers
Sponsor: Valenta Pharm JSC
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: IFR-01-01-2024
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators